Represented Hoffmann-La Roche Inc. and Genentech, Inc. in multiple Hatch-Waxman suits to prevent generic drug companies from launching at-risk generic versions of the branded osteoporosis drug Boniva®. Secured a critical claim construction victory and three preliminary injunctions on patent covering the active ingredient.
-
合伙人 -
合伙人
-
合伙人
-
Co-Chair, Life Sciences; Chair, Patent Litigation & Counseling